PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23633496-0	2013	Rare APOA5 promoter variants associated with paradoxical HDL cholesterol decrease in response to fenofibric acid therapy.	fenofibric acid	97-112	apolipoprotein A5	Homo sapiens	5-10	
23633496-3	2013	The APOA5 gene region was sequenced in 1,612 individuals with mixed dyslipidemia in a randomized trial of fenofibric acid alone and in combination with statins.	fenofibric acid	106-121	apolipoprotein A5	Homo sapiens	4-9	
23633496-5	2013	Rare APOA5 promoter region variants were associated with decreased HDL-C and apoA-I levels in response to fenofibric acid therapy; rare missense variants were associated with increased TG response to combination therapy.	fenofibric acid	106-121	apolipoprotein A5	Homo sapiens	5-10	
21889769-0	2011	Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.	fenofibric acid	91-106	apolipoprotein A5	Homo sapiens	16-21